69062-86-8

Usage

Uses

Used in Pharmaceutical Industry:
2,4-Dimethyloxazole-5-carboxaldehyde is utilized as an intermediate in the synthesis of pharmaceuticals, contributing to the development of new drugs and medicinal compounds. Its unique chemical structure allows it to be a key component in creating a variety of therapeutic agents.
Used in Organic Compounds Synthesis:
In the realm of organic chemistry, 2,4-Dimethyloxazole-5-carboxaldehyde is employed as an intermediate for synthesizing other organic compounds. Its versatility in chemical reactions makes it a valuable asset in the creation of diverse chemical entities.
Used in Research and Development:
2,4-Dimethyloxazole-5-carboxaldehyde is extensively used in research and development settings, where its properties and reactivity are explored to advance scientific understanding and innovation in chemical and material sciences.
Used in Industrial Applications:
2,4-Dimethyloxazole-5-carboxaldehyde finds application in various industrial processes, particularly in the production of chemicals and materials that require its specific chemical characteristics for their synthesis.
Safety Note:
It is crucial to handle 2,4-Dimethyloxazole-5-carboxaldehyde with care and adhere to safety guidelines, as it can pose hazards if not used properly. Its potential risks should be managed through appropriate safety measures to ensure the well-being of individuals and the environment.

InChI:InChI=1/C6H7NO2/c1-4-6(3-8)9-5(2)7-4/h3H,1-2H3

Upstream product

• 23012-30-8 2,4-dimethyloxazole-5-ylcarboxylate ethyl ester 
• 214553-55-6 5-hydroxymethyl-2,4-dimethyloxazole 

Downstream Products

• 874277-98-2 C₂₇H₃₃N₅O 
• 1599529-59-5 (4-chloro-2-methoxy-3-(4-(trifluoromethyl)benzyl)quinoline-6-yl)(2,4-dimethyloxazol-5-yl)methanol 
• 23012-25-1 2,4-dimethyl-5-acetyloxazole 
• 1616100-75-4 (R)-N-((S)-2-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-4-(2,4-dimethyloxazol-5-yl)-4-oxobutan-2-yl)-2-methylpropane-2-sulfinamide 
• 1616100-76-5 (R)-N-((2S,4R)-2-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-4-(2,4-dimethyloxazol-5-yl)-4-hydroxybutan-2-yl)-2-methylpropane-2-sulfinamide 
• 1616100-77-6 (1R,3S)-3-amino-3-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-1-(2,4-dimethyloxazol-5-yl)butan-1-ol 
• 1616100-78-7 N-(((2S,4R)-2-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-4-(2,4-dimethyloxazol-5-yl)-4-hydroxybutan-2-yl)carbamothioyl)benzamide 
• 1616100-26-5 (4S,6S)-4-(2,4-difluoro-5-(pyrimidin-5-yl)phenyl)-6-(2,4-dimethylisoxazol-5-yl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine 

Relevant academic research and scientific papers

Synthesis of oxazolyl- and furanyl-substituted imidazole hydrochlorides and methiodides

Oxazolyl-5- and furanyl-2-substituted imidazoles have been synthesized by coupling the two ring systems via the dipolar cycloadditon of tosyl methyl isocyanide to the corresponding oxazolyl and furanyl aldimines in basic media. These substitute oxazolyl and furanylimidazole bases obtained in this manner were then subjected to hydrogen chloride gas and to methyl iodide to form the corresponding hydrochlorides and methyliodides, respectively. All compounds were purified, characterized and then tested for muscarinic binding affinity. Biological test results revealed low muscarinic receptor affinity and selectivity.

1-cyclopropyl-4-pyridyl-quinolinones

Compounds of formula STR1 wherein R1 is hydrogen, lower-alkyl, or trifluoromethyl; R2 is lower-alkyl, trifluoromethyl or CH2 Z where Z is hydroxy, chloro, lower-alkylamino or dilower-alkylamino; R3 and R4 are each individually hydrogen or fluoro; and Ar is phenyl, an aromatic 5- or 6-membered heterocycle or any of these substituted at one or more positions with lower-alkyl, fluoro, chloro, hydroxy, amino, lower-alkylamino, dilower-alkylamino, carboxy, sulfonamido, lower alkylsulfonamido, methylenedioxy, trifluoroacetamido, lower-alkanoylamino, or carbamoyl; and their pharmaceutically acceptable acid addition salts are useful as anticancer agents.